INTRODUCTION {#sec1-1}
============

*Dianthus superbus* belonging to the Caryophyllaceae family is widely distributed in China and Korea. *D. superbus* is a traditional herbal medicine for treating urethritis, carbuncles and carcinoma. Previous studies on *D. superbus* showed various biologically activities, including antioxidant, antimicrobial, anticancer, and anti-inflammatory activity.\[[@ref1][@ref2][@ref3]\] *D. superbus* also showed immunosuppressive effects, osteoblastic proliferative, suppress immunoglobulin E production and prevent peanut-induced anaphylaxis.\[[@ref4][@ref5][@ref6][@ref7]\] Especially, ethyl acetate fraction of *D. superbus* was found to possess the cytotoxic activity against cancer cells.\[[@ref8]\] Dianthosaponins, dianthramide, flavonoid, coumarin, triterpenoid, pyran type glycoside, and cyclic peptides have been isolated from *D. superbus*.\[[@ref9][@ref10][@ref11][@ref12][@ref13][@ref14][@ref15]\] We isolated eight compounds, (E)-methyl-4-hydroxy-4-(8a-methyl-3- oxodecahydronaphthalen-4a-yl) (1), diosmetin-7-O (2\'\',6\'\'-di-O-α-L- rhamnopyranosyl)-β-D- glucopyranoside (2), vanillic acid (3), 4-hydroxyphenyl acetic acid (4), 4-methoxyphenyl acetic acid (5), (E)-4-methoxycinnamic acid (6), 3-methoxy-4-hydroxyphenylethanol (7), and methyl hydroferulate (8) from *D. superbus* and these compounds were used for simultaneous determination of *D. superbus*.

Herbal medicines are composed with various chemical compounds such as flavonoids, terpenoids, saponins, and phenols. These diversity compounds exhibited therapeutic efficacy of herbal medicines, but make some difficulties at quality control of herbal medicine. The contents of bioactive compounds were depended on the location, climate, and other cultivation factor. Considering these various factors, the quality control of the raw herbal medicines such as *D. superbus* has become important. Recently, many researchers develop analytical methods for quality control due to increase use of herbal medicines. Among the analytical methods, high performance liquid chromatography (HPLC) is the most popular one, because of its easy operation, side suitability, and high accuracy.\[[@ref16]\]

In this paper, a simple and accurate HPLC-diode array detector (DAD) method was firstly developed and validated for the simultaneous determination of the eight compounds in *D. superbus*. This method was successfully applied to simultaneous quantification of *D. superbus* samples.

MATERIALS AND METHODS {#sec1-2}
=====================

Chemicals and reagents {#sec2-1}
----------------------

The herbal samples of *D. superbus* were obtained from Kyungdong traditional herbal market in Seoul, Korea and identified by Dr. Young Bae Seo, a professor of the College of Oriental Medicine, Daejeon University, Korea. A voucher specimen (CJ004M) has been deposited in the natural products laboratory, the Kangwon National University, Chuncheon, Korea. D-1--D-7 and D-8--D-12 samples were originated from Korea and China, respectively.

HPLC grade water and acetonitrile was purchased from J.T. Baker. Analytical grade trifluoroacetic acid (TFA) was obtained from Dae Jung.

Isolation of compounds {#sec2-2}
----------------------

(E)-methyl-4-hydroxy-4-(8a-methyl-3-oxodecahydronaphthalen-4a-yl) (1), diosmetin-7-O (2\'\',6\'\'-di-O-α-L-rhamnopyranosyl)-β-D- glucopyranoside (2), vanillic acid (3), 4-hydroxyphenyl acetic acid (4), 4-methoxyphenyl acetic acid (5), (E)-4-methoxycinnamic acid (6), 3-methoxy-4- hydroxyphenylethanol (7), and methyl hydroferulate (8) were isolated in our laboratory \[[Figure 1](#F2){ref-type="fig"}\]. The structures were confirmed by comparing their mass spectrometer and nuclear magnetic resonance data with literature data.\[[@ref17][@ref18][@ref19][@ref20][@ref21][@ref22][@ref23][@ref24]\] The purities of the eight standard compounds were above 98%.

![Chemical structures of compounds 1-8. 1: (E)-methyl-4-hydroxy-4-(8a-methyl-3-oxodecahydronaphthalen-4a-yl); 2: Diosmetin-7-O (2'',6''-di-O-α-L-rhamnopyranosyl)-β-D-glucopyranoside; 3: Vanillic acid; 4: 4-hydroxyphenyl acetic acid; 5: 4-methoxyphenyl acetic acid; 6: (E)-4-methoxycinnamic acid, 7: 3-methoxy-4-hydroxyphenylethanol 8: Methyl hydroferulate](PM-12-264-g002){#F2}

Eight compound was isolated to a silica gel open column chromatography (CC) (90 cm × 10 cm, 70--230 mesh) using a gradient of n-hexane-EtOAc (100:1 → 0:1, v/v) on the EtOAc fraction.

7 fractions (A--G) were obtained from EtOAC fraction. Fraction F was performed to silica gel CC (EtOAc-MeOH from 50:1--0:1, v/v) to obtained 9 fractions (F1--F9).

Fraction F7 was subjected to medium-pressure liquid chromatography (MPLC) and four sub-fractions were collected. Compound 1 (51.3 mg) was purified with the Sephadex LH-20 and the MPLC.

Among the compounds, compound 1, (E)-methyl-4-hydroxy-4- (8a-methyl-3-oxodecahydronaphthalen- 4a-yl) was first isolated. (E)-methyl-4-hydroxy-4-(8a-methyl-3-oxodecahydronaphthalen-4a-yl) Yellow oil; ^1^H NMR (CD~3~ OD 400 MHz): δ 0.94 (3H, *s*, H-11), δ 1.17--2.31 (10H, *m*, H-4, 5, 6, 7, 9), δ 2.40--2.77 (4H, *m*, H-2, 10), δ 3.73 (3H, *s*, H-16), δ 3.89 (1H, *dd*, *J* = 7.58, 2.85 Hz, H-12), δ 6.01 (1H, *dd*, *J* = 15.26, 5.43 Hz, H-13), δ 6.16 (1H, *dd*, *J* = 15.26, 1.06 Hz, H-14).^13^ C NMR (CD~3~ OD 100 MHz) δ 18.20 (C-11), δ 23.01 (C-5), δ 23.77 (C-6), δ 29.00 (C-4), δ 29.14 (C-7), δ 33.77 (C-8), δ 36.85 (C-9), δ 42.28 (C-10), δ 50.99 (C-16), δ 52.27 (C-3), δ 52.95 (C-2), δ 77.40 (C-12), δ 139.67 (C-13), δ 124.67 (C-14), δ 174.99 (C-15), δ 210.25 (C-1).

Standard solution and Sample preparation {#sec2-3}
----------------------------------------

Eight Standard compounds, (E)-methyl-4-hydroxy-4-(8a-methyl-3- oxodecahydronaphthalen-4a-yl) (200 μg/ml), diosmetin- 7-O (2\'\',6\'\'-di-O-α-L-rhamnopyranosyl)-β-D-glucopyranoside (200 μg/ml), vanillic acid (200 μg/ml), 4-hydroxyphenyl acetic acid (200 μg/ml), 4-methoxyphenyl acetic acid (200 μg/ml), (E)-4-methoxycinnamic acid (200 μg/ml), and 3-methoxy-4-hydroxyphenylethanol (200 μg/ml) were accuracy weighed and prepared in methanol. These were diluted to prepare solutions with six different concentrations for the establishment of calibration curves. Solutions were filtered through 0.45 µm membrane filter before HPLC analysis. Then, all solutions were stored in the refrigerator at 4°C.

Dried *D. superbus* extract powders were correctly weighed (10 mg) and dissolved in methanol (1 ml). These extract solutions also were filtered through a 0.45 µm membrane filter before sample injection.

High performance liquid chromatography-diode array detector analysis {#sec2-4}
--------------------------------------------------------------------

The HPLC system is consisted of Dionex system with LPG 3X00 pump, ACC-3000 auto sampler, column oven, and DAD-3000(RS) DAD ultraviolet (UV)--visible. Separation was accomplished using a Shiseido C~18~ column (4.6 mm ID × 250 mm, 5 µm pore size). Column temperature was maintained at 30°C. The mobile phase was composed of 0.1% TFA aqueous solution (A) and acetonitrile (B) at a flow rate of 1.0 ml/min. The gradient flows were as follows: 15% B at 0--10 min, 15--25% B at 10--15 min, 25--70% B at 15--40 min, 70% B at 40--45 min. The injection volume was 20 µL. The wavelength of UV detection was set at 205 and 280 nm, respectively.

Calibration curves and limits of detection and quantification {#sec2-5}
-------------------------------------------------------------

The stock standard mixture was diluted with methanol to appropriate concentration ranges for the construction of calibration curves. Calibration curves were established by plotting the peak area (y) versus concentration (x) of each analyte. The linearity was measured by correlation coefficient (*R*^2^) values. Limit of detection (LOD) and quantification (LOQ) were determined using signal-to-noise ratios (S/N) of 3 and 10, respectively.

Precision and recovery {#sec2-6}
----------------------

Intra- and inter-day test were conducted to determine the precision of the developed method. Validation of HPLC method with precision and recovery was performed according to the International Conference on Harmonization guidelines.\[[@ref25]\] The intraday test was analyzed by standard solutions at three different concentrations on the single day and the inter-day test was performed on the three different days (1, 3, 5 days). In order to confirm the repeatability, each sample was analyzed 5 times as described above. The relative standard deviation (RSD) was taken as a measure of repeatability. RSD value determined repeatability of method.

Recovery test was used to investigate the accuracy of this analysis method. The standard solutions with known three different concentrations (5.56, 2.78, and 1.39 µg/mL) were added to *D. superbus* sample and then analyzed in 3 times. Recovery was calculated by the equation.

Recovery = (Amount found − original amount)/amount spiked × 100

RESULTS AND DISCUSSION {#sec1-3}
======================

Method development {#sec2-7}
------------------

To obtain optimal analytic conditions, various HPLC parameters were tested, including column, mobile phase, and gradient elution system and flow rate. Based on the resolution, baseline and retention time, the analytical conditions were optimized. To improve the peak shape, TFA was added to the water. The detection wavelength was optimized at 205 nm for (E)-methyl-4-hydroxy-4-(8a-methyl-3- oxodecahydronaphthalen-4a-yl), diosmetin-7-O (2\'\',6\'\'-di-O-α-L-rhamnopyranosyl)-β-D- glucopyranoside, vanillic acid, 3-methoxy-4-hydroxyphenylethanol and methyl hydroferulate and 280 nm for 4-hydroxy-phenylacetic acid, 4-methoxyphenylacetic acid, (E)-4-methoxycinnamic acid. About 20 μl was found to be the suitable injection volume. All peak of each compound were separated successful within 45 min. HPLC chromatogram of the eight compounds is shown in [Figure 2](#F3){ref-type="fig"}. The peaks of each compound were confirmed by comparing their retention time in the HPLC chromatogram and the UV spectrum.

![Chromatograms of standard compounds (a) and extract from *Dianthus superbus* (b). 1: (E)-methyl-4-hydroxy-4-(8a-methyl-3-oxodecahydronaphthalen-4a-yl); 2: Diosmetin-7-O (2'',6''-di -O-α-L-rhamnopyranosyl)-β-D-glucopyranoside; 3: Vanillic acid; 4: 4-hydroxyphenyl acetic acid; 5: 4-methoxyphenyl acetic acid; 6: (E)-4-methoxycinnamic acid; 7: 3-methoxy-4-hydroxyphenylethanol; 8: Methyl hydroferulate](PM-12-264-g003){#F3}

Method validation {#sec2-8}
-----------------

Calibration curves with six concentrations of standard solution were conducted in the concentration range of 0.69--22.22 µg/ml. The calibration data of the eight compounds showed a good linearity (*R*^2^ \> 0.98). LOD and LOQ, which were measured by calibration curve, were in the range 0.12--1.91 μg/ml and 0.37--5.80 μg/ml, respectively \[[Table 1](#T1){ref-type="table"}\].

###### 

The regression data, limits of detection and limits of quantifications for eight compounds analyzed by HPLC-DAD

![](PM-12-264-g004)

In inter- and intra-day test, the RSD values were taken as a measure of precision. As a result, the RSD values of the intra- and inter-day tests were found to be within the ranges 0.32--2.81% and 0.25--2.92%, respectively. And accuracy of intra- and inter-day was ranged from 91.14--109.70% and 93.61--108.49%, respectively \[[Table 2](#T2){ref-type="table"}\]. The recovery of the selected maker compounds ranged from 96.23 to 109.87%, and their RSD values were \<2.73% \[[Table 3](#T3){ref-type="table"}\].

###### 

Intra- and inter-day precision of eight compounds. (E)-methyl-4-hydroxy-4-(8a-methyl-3-oxodecahydronaphthalen-4a-yl) (1), diosmetin-7-O (2",6"-di-O-α-L-rhamnopyranosyl)-α-D-glucopyranoside (2), vanillic acid (3), 4-hydroxyphenyl acetic acid (4), 4-methoxyphenyl acetic acid (5), (*E*)-4-methoxycinnamic acid (6), 3-methoxy-4-hydroxyphenylethanol (7), and methyl hydroferulate (8)

![](PM-12-264-g005)

###### 

Recovery of the eight compounds. (E)-methyl-4-hydroxy-4-(8a-methyl-3-oxodecahydronaphthalen-4a-yl) (1), diosmetin-7-O (2",6"-di-O-α-L-rhamnopyranosyl)-β-D-glucopyranoside (2), vanillic acid (3), 4-hydroxyphenyl acetic acid (4), 4-methoxyphenyl acetic acid (5), (E)-4-methoxycinnamic acid (6), 3-methoxy-4-hydroxyphenylethanol (7), and methyl hydroferulate (8)

![](PM-12-264-g006)

*Dianthus superbus* samples analysis and cluster analysis {#sec2-9}
---------------------------------------------------------

The newly established analytical method was applied to the analysis of eight compounds in 12 *D. superbus* samples (D-1--D-12) from various regions. The samples were analyzed using the optimized HPLC condition in triplicate to determine the mean content. The contents of eight compounds in *D. superbus* were calculated from the calibration curves of standard. [Table 4](#T4){ref-type="table"} exhibited the results of sample analysis. The results show that 4-hydroxy-phenylacetic acid was the highest content (83.21--85.58 μg/mg) among the isolated compounds in *D. superbus* sample. Contents of 4-methoxyphenylacetic acid (0.87--1.27 μg/mg) and methyl hydroferulate (1.35--1.68 μg/mg) were lower than other compounds in 12 *D. superbus* samples.

###### 

Contents of eight compounds in 12 Dianthus superbus samples

![](PM-12-264-g007)

We performed hierarchical cluster analysis (HCA) using IBM SPSS Statistics 21 (SPSS Inc., an IBM Company). Samples were investigated based on contents of eight compounds. HCA analysis has shown difference among different *D. superbus* sample origins. Difference from samples was represented by Euclidean distance \[[Figure 3](#F4){ref-type="fig"}\]. Samples were divided into three clusters (I, II, III). Cluster I consisted of samples originated from Korea exclude D-10 and D-11 samples. Cluster II and III consisted of samples originated from China exclude D-3 sample. The samples clustered one group was associated with similar content of compounds. The result showed contents of compounds in *D. superbus* samples is different by cultivation environment and provided reference for the quality control of *D. superbus*.

![Dendrogram of cluster analysis for 12 *Dianthus superbus* samples](PM-12-264-g008){#F4}

Simultaneous determination of eight compounds, (E)-methyl-4-hydroxy-4-(8a-methyl-3- oxodecahydronaphthalen-4a-yl) (1), diosmetin-7-O (2\'\',6\'\'-di-O-α-L-rhamnopyranosyl)-β-D-glucopyranoside (2), vanillic acid (3), 4-hydroxyphenyl acetic acid (4), 4-methoxyphenyl acetic acid (5), (E)-4-methoxycinnamic acid (6), 3-methoxy-4- hydroxyphenylethanol (7), and methyl hydroferulate (8) in *D. superbus* was established for quantitative analysis of *D. superbus* and method validation including linearity, precision and accuracy. The results of linearity indicate that this established method has high sensitivity. Intra- and inter-day variability assays were used to determine the precision of the developed method and this result demonstrated good reproducibility of this analytical method. Recovery test was performed to evaluate the accuracy of this method. The results showed that the established method was reliable and accurate.

This developed method was successfully analyzed contents of eight compounds in 12 *D. superbus* samples. In addition, we confirmed that content of *D. superbus* is different between cultural environment, such as area and climate.

CONCLUSION {#sec1-4}
==========

In this study, we developed the simultaneous determination of eight compounds, (E)-methyl-4-hydroxy-4- (8a-methyl-3- oxodecahydronaphthalen-4a-yl) (1), diosmetin-7-O (2\'\',6\'\'-di-O-α-L-rhamnopyranosyl)-β-D-glucopyranoside (2), vanillic acid (3), 4-hydroxyphenyl acetic acid (4), 4-methoxyphenyl acetic acid (5), (E)-4-methoxycinnamic acid (6), 3-methoxy-4- hydroxyphenylethanol (7), and methyl hydroferulate (8) in *D. superbus* for quality control using HPLC-DAD.

This HPLC-DAD method was applied for simultaneous determination of *D. superbus* sample under optimized HPLC conditions. The results of method validation demonstrated that this developed method was sensitive, reliable and reproducible for simultaneous determination of *D. superbus*. Thus, this study may be provided analysis method for quality evaluation and identification of medicinal effect of *D. superbus* by using a HPLC-DAD.
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